News

2017

The Availability of direct-acting antivirals is reducing disparities in the uptake of hepatitis C treatment
by aidsmap

Fast Facts: Hepatitis C treatment cascade and developments in access to treatment
by CATIE

Previously Cured HCV Patients Can Be Reinfected- Prevention will require attention to high-risk behaviors
by Medpage Today

HCV Rare in Kids; Treatment Isn’t straightforward- DAAs may be around the corner for children, but many considerations
by Medpage Today

Late Diagnosis of hepatitis C in people with advanced liver injury decreasing in B.C.
by CATIE Hep C info

The Power of Health Research
by CIHR

SPPH Post- doctoral fellows win Banting, MSFHR Award
by SPPH

Looking at the Twin Epidemics of HCV
by MedPage Today

HCV Moving closer to Eradication- funding, lower drug costs could win fight against HCV
by MedPage Today

Incidence, risk factors, and prevention of hepatitis C reinfection: a population-based cohort study.
by HCV Trials (expert commentary)

The Hepatitis C Care Cascade: From Diagnosis to Care and Treatment in British Columbia
by Pacific Aids Network

Opoid Addiction Treatment and Psychotherapy Tied to Less HIV Risk in Those with Hepatitis C
by Hep Magazine

Counselling and opioid subsititution therapy could reduce risk of hepatitis C reinfection
by UBC Medicine

 

2016

Targeted services needed to prevent new Hep C infections
by School of Population & Public Health, University of British Columbia

Twin epidemics of new and prevalent hepatitis C infections in Canada: BC Hepatitis Testers Cohort
by MDLinx

Liver Cancer Risk Reduced After Hepatitis C Treatment, But Vigilance Needed
by HIV and Hepatitis

Liver Cancer Risk Reuced after hepatitis C treatment, but vigilance needed for aggressive cancers in months after treatment
by AIDSmap

DAA treatment reduces risk of HCC for most hepatitis C patients
by Medical Brief

The impact of sustained virological response to HCV infection on long term risk of hepatocellular carcinoma: the BC Hepatitis Testers Cohort

by HepC BC

Impact of treatment induced vs, spontaneous HCV clearance on the long term risk of hepatocellular carcinoma: BC Hepatitis Testers Cohort
by NATAP

Impact of Drug Use and Opoid Substitution therapy on Hepatitis C Reinfection: The BC Hepatitis Testers Cohort
by NATAP

The impact of Sustained Virological response to HCV infection on long term risk of hepatocellular carcinoma: The BC Hepatitis Testers Cohort
by NATAP

SVR Post-interferon-based-therapy reduces, not eliminates risk of HCC
by Healio

Liver Cancer Risk Reduced after Hepatitis C treatment, but vigilance needed
by Eat.org

Incidence, Risk Factors and Prevention of Hepatitis C Reinfection
by Medical Research

Highs and No Lows
by Valley Voice